Waystone Advisors »

United Therapeutics Corporation shares owned by Waystone Advisors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Waystone Advisors from 13F filings

Historical chart of Waystone Advisors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Waystone Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Waystone Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $306k 628 487.27

More positions owned by Waystone Advisors

Microsoft Corporation (MSFT)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Amazon (AMZN)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Global X Fds Us Infr Dev Etf (PAVE)
Spdr Series Trust State Street Spd (SPYG)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Core Msci Eafe (IEFA)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)

View all positions for Waystone Advisors

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
Invesco
Assetmark
Caption Management
Dimensional Fund Advisors
LMR Partners

View all funds holding United Therapeutics Corporation